1
|
Strosberg JR: Update on the management of
unusual neuroendocrine tumors: pheochromocytoma and paraganglioma,
medullary thyroid cancer and adrenocortical carcinoma. Semin Oncol.
40:120–133. 2013.
|
2
|
Pinto FR, Capelli Fde A, Maeda SA, et al:
Unusual location of a cervical paraganglioma between the thyroid
gland and the common carotid artery: case report. Clinics (Sao
Paulo). 63:845–848. 2008.
|
3
|
Schmit GD, Gorman B, van Heerden JA and
Gharib H: Inferior laryngeal paraganglioma mimicking a primary
thyroid tumor. Endocr Pract. 12:432–435. 2006.
|
4
|
Baysal BE, Ferrell RE, Willett-Brozick JE,
et al: Mutations in SDHD, a mitochondrial complex II gene, in
hereditary paraganglioma. Science. 287:848–851. 2000.
|
5
|
Astuti D, Latif F, Dallol A, et al: Gene
mutations in the succinate dehydrogenase subunit SDHB cause
susceptibility to familial pheochromocytoma and to familial
paraganglioma. Am J Hum Genet. 69:49–54. 2001.
|
6
|
Niemann S and Müller U: Mutations in SDHC
cause autosomal dominant paraganglioma, type 3. Nat Genet.
26:268–270. 2000.
|
7
|
Bayley JP, van Minderhout I, Weiss MM, et
al: Mutation analysis of SDHB and SDHC: novel germline mutations in
sporadic head and neck paraganglioma and familial paraganglioma
and/or pheochromocytoma. BMC Med Genet. 7:12006.
|
8
|
Havekes B, King K, Lai EW, et al: New
imaging approaches to phaeochromocytomas and paragangliomas. Clin
Endocrinol (Oxf). 72:137–145. 2010.
|
9
|
Sharma P, Thakar A, Suman KS, et al:
68Ga-DOTANOC PET CT for baseline evaluation of patients with head
and neck paraganglioma. J Nucl Med. 54:841–847. 2013.
|
10
|
Gabriel S, Blanchet EM, Sebag F, et al:
Functional characterization of nonmetastatic paraganglioma and
pheochromocytoma by F-FDOPA PET: focus on missed lesions. Clin
Endocrinol (Oxf). 79:170–177. 2013.
|
11
|
Schreiner AM, Fried K and Yang GC:
Interconnecting cytoplasmic processes on fine-needle aspiration
smears of carotid body paraganglioma. Diagn Cytopathol. 38:507–508.
2010.
|
12
|
Tischler AS: Pheochromocytoma and
extra-adrenal paraganglioma: updates. Arch Pathol Lab Med.
132:1272–1284. 2008.
|
13
|
Thompson LD: Pheochromocytoma of the
Adrenal gland Scaled Score (PASS) to separate benign from malignant
neoplasms: a clinicopathologic and immunophenotypic study of 100
cases. Am J Surg Pathol. 26:551–566. 2002.
|
14
|
Offergeld C, Brase C, Yaremchuk S, et al:
Head and neck paragangliomas: clinical and molecular genetic
classification. Clinics (Sao Paulo). 67:19–28. 2012.
|
15
|
Lahlou-Laforêt K, Consoli SM, Jeunemaitre
X, et al: Presymptomatic genetic testing in minors at risk of
paraganglioma and pheochromocytoma: our experience of oncogenetic
multidisciplinary consultation. Horm Metab Res. 44:354–358.
2012.
|